-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA GRANTS SEASTAR MEDICAL BREAKTHROUGH DEVICE DESIGNATION FOR ITS SCD THERAPY FOR THE TREATMENT OF HYPERINFLAMMATION IN ADULT PATIENTS WITH SEPSIS OR A SEPTIC CONDITION

Reuters·10/07/2026 12:18:04